Download the provisional programme by clicking here.
Access registration through this link: https://bit.ly/2UNmzML
Medical Product Alert N°2/2026: Falsified JAKAVI (ruxolitinib) Falsified JAKAVI (ruxolitinib) identified in the WHO Eastern Mediterranean and European regions